Nf2 Biosolutions
- Assets
- $712.4k
- Revenue
- $772.3k
- Investments
- $0.0
- Employees
- 0
- Location
- West Chester, PA
- Founding
- 07/2018
- Data as of
- 12/2023
- EIN
- 83-0940046
Organization Overview
Nf2 Biosolutions is located in West Chester, PA. The organization was established in 2018. According to its NTEE Classification (G20) the organization is classified as: Birth Defects & Genetic Diseases, under the broad grouping of Voluntary Health Associations & Medical Disciplines and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Nf2 Biosolutions is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2023, Nf2 Biosolutions generated $772.3k in total revenue. This organization has experienced exceptional growth, as over the past 5 years, it has increased revenue by an average of 11.4% each year . All expenses for the organization totaled $966.4k during the year ending 12/2023. You can explore the organizations financials more deeply in the financial statements section below.
Since 2021, Nf2 Biosolutions has awarded 21 individual grants totaling $1,118,826. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2023
Describe the Organization's Mission:
Part 3 - Line 1
SEEKING A CURE OR PREVENTATIVE TREATMENT FOR NF2 BY VIGOROUSLY SUPPORTING AND ADVANCING EXISTING AND NEXT GENERATION BIOMEDICAL TECHNOLOGIES SUCH AS GENE TRANSFER THERAPY AND IMMUNONTHERAPY
Describe the Organization's Program Activity:
Part 3 - Line 4a
THE ORGANIZATION IS FUNDING RESEARCH INTO A CURE FOR NF2. THE ORGANIZATION ARRANGED A CONSORTIUM IN 2019, WHICH WAS ATTENDED BY LEADING EXPERTS IN THE FIELDS OF NF2 RESEARCH AND GENE THERAPY. FROM THIS CONSORTIUM THE ORGANIZATION IDENTIFIED LABORATORIES WHICH ARE WORKING ON DIFFERENT APPROACHES THAT MAY LEAD TO A CURE OR IMPROVED TREATMENT FOR NF2. THE ORGANIZATION IS NOW PROVIDING SUPPORT TO THESE LABORATORIES, AND IS ORGANIZING ANOTHER CONSORTIUM TO SEEK ADDITIONAL LABORITORIES TO SUPPORT.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Nicole Henwood President | Officer | 20 | $49,600 |
Gilles Atlan Vice President | Officer | 20 | $16,000 |
Brian Clay Director | Trustee | 1 | $0 |
Penny Henwood Director | Trustee | 1 | $0 |
Amy Williams Director | Trustee | 5 | $0 |
Terri Rausch Director | Trustee | 5 | $0 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $0 |
| Government grants | $0 |
| All other contributions, gifts, grants, and similar amounts not included above | $759,785 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $759,785 |
| Total Program Service Revenue | $0 |
| Investment income | $0 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $0 |
| Net Income from Fundraising Events | $12,551 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $772,336 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $735,156 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $0 |
| Compensation of current officers, directors, key employees. | $0 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $0 |
| Pension plan accruals and contributions | $0 |
| Other employee benefits | $0 |
| Payroll taxes | $0 |
| Fees for services: Management | $127,265 |
| Fees for services: Legal | $65,329 |
| Fees for services: Accounting | $9,700 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $3,438 |
| Advertising and promotion | $3,873 |
| Office expenses | $4,995 |
| Information technology | $39 |
| Royalties | $0 |
| Occupancy | $0 |
| Travel | $2,856 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $0 |
| Interest | $6,432 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $0 |
| Insurance | $1,148 |
| All other expenses | $0 |
| Total functional expenses | $966,416 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $602,390 |
| Savings and temporary cash investments | $0 |
| Pledges and grants receivable | $0 |
| Accounts receivable, net | $0 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $0 |
| Net Land, buildings, and equipment | $0 |
| Investments—publicly traded securities | $0 |
| Investments—other securities | $0 |
| Investments—program-related | $110,000 |
| Intangible assets | $0 |
| Other assets | $0 |
| Total assets | $712,390 |
| Accounts payable and accrued expenses | $0 |
| Grants payable | $0 |
| Deferred revenue | $0 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $101,900 |
| Other liabilities | $0 |
| Total liabilities | $101,900 |
| Net assets without donor restrictions | $610,490 |
| Net assets with donor restrictions | $0 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $712,390 |
Grants Awarded
Over the last fiscal year, Nf2 Biosolutions has awarded $734,156 in support to 11 organizations.
| Grant Recipient | Amount |
|---|---|
CHOP RESEARCH INSTITUTE PURPOSE: developing a tumor biobank for NF2 | $0 |
MASS GEN DEVELOPMENT OFFICE PURPOSE: development of bacteriotherapy for NF2 | $60,512 |
YALE UNIVERSITY PURPOSE: tumor imaging model | $36,351 |
UNIVERSITY OF CALIFORNIA PURPOSE: research | $812 |
INSTITUTE FOR CANCER RESEARCH PURPOSE: research | $0 |
INDIANA UNIVERSITY RESEARCH PURPOSE: research | $47,007 |